Profound Medical (TSE:PRN) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Profound Medical Corp. is set to launch a public offering of common shares, aiming to raise funds for the expansion and commercialization of their TULSA-PRO and Sonalleve systems. The offering will be managed by Raymond James Ltd. and Lake Street Capital Markets and is expected to close by December 10, 2024, subject to market conditions and approvals.
For further insights into TSE:PRN stock, check out TipRanks’ Stock Analysis page.
